FBIO Stock Analysis: Buy, Sell, or Hold?
FBIO - Fortress Biotech, Inc.
$2.86
0.09 (3.25%)
▲
5d:
+0.35%
30d:
+24.35%
90d:
-7.44%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When FBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: FBIO shows positive signals but monitor for confirmation. Market pricing in 67.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: FBIO shows positive signals but monitor for confirmation. Market pricing in 67.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$0.60
Based on -37.5% avg growth
INTRINSIC VALUE TODAY
$0.37
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FBIO is currently trading at $2.86, which is considered extended relative to its 30-day fair value range of $2.41 to $2.82. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.7) compared to its historical average (164.5). Remarkably, the market is currently pricing in an annual earnings decline of 67.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, FBIO is in a strong downtrend. Immediate support is located at $2.53, while resistance sits at $3.00. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.00 (+284.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, FBIO is in a strong downtrend. Immediate support is located at $2.53, while resistance sits at $3.00. The stock is showing strong short-term momentum, up 3.2% recently.
Market Sentiment: FBIO has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.00 (+284.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.41 -
$2.82
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
73.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.2%)
- BULLISH: Trading 284.6% below Wall St target ($11.00)
Trading Range Analysis
30-Day Trading Range
$2.41 -
$2.82
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.39
(13.5%)
Support & Resistance Levels
Support Level
$2.53
Resistance Level
$3.00
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
5.66
Wall Street Target
$11.00
(+284.6%)
Revenue Growth (YoY)
22.1%
Profit Margin
193.1%
Valuation Discount vs History
-67.5% cheaper
PE vs Historical
5.7 vs 164.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-67.5%
(market-implied from PE analysis)
1-Year Target
$2.57
(-10%)
2-Year Target
$2.32
(-19%)
3-Year Target
$2.08
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6→165)
$60.56
(+2018%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: -79.0%)
$8.02
(+180%)
Base:
(SPY PE: 5.7, Growth: -79.0%)
$2.08
(-27%)
Bear:
(PE: 4.8, Growth: -79.0%)
$1.77
(-38%)
📈
Valuation based on Current Earnings
Trailing PE: 0.86 | Current EPS (TTM): $3.23
Bull Case
$1.52
(-47%)
Analyst growth -50.0%, PE expands to 0.9
Base Case
$1.39
(-52%)
Market implied -50.0%, PE stable at 0.9
Bear Case
$1.88
(-34%)
Severe decline -20.0%, PE contracts to 0.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.7 to 164.5
Stabilization Target:
$83.07
(+2804.6%)
PE Expansion Potential:
+2804.6%
Share & Embed Analysis
Last updated: June 15, 2026 9:31 PM ET
Data refreshes hourly during market hours. Next update: 10:31 PM
Data refreshes hourly during market hours. Next update: 10:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 62 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 55 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 57 HOLD |
